Tag: acute myeloid leukemia

March 18, 2019

Rafael Pharma Stands Out with Drugs Treating Difficult Cancers

INN spoke with Rafael Pharmaceuticals' CEO about the company's lead drug candidate, CPI-613, and how it's treating difficult cancers.
March 6, 2019

Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia

Bio-Path Holdings (NASDAQ:BPTH) has announced a clinical update on its interim analysis from the Phase 2 trial of prexigebersen (BP1001)...
December 13, 2018

Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436

Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, announced today that the first patient...
November 22, 2018

Genentech Announces FDA Grants Venclexta Accelerated Approval

Genentech, a member of the Roche Group (SIX:RO,ROG;OTCQX:RHHBY), announced that the U.S. Food and Drug Administration (FDA) has granted accelerated...
October 18, 2018

Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia in China

Hutchison China MediTech (AIM/Nasdaq:HCM) has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase inhibitor, in combination...
September 27, 2018

Aptose Biosciences and CrystalGenomics Announce Issuance of European Patent for CG-806

Aptose Biosciences (NASDAQ:APTO, TSX:APS), today announced that the European Patent Office has issued European Patent No. EP2940014B1 for CG-806, a...